Perioperative and intraoperative pain and anesthetic care of the chronic pain and cancer pain patient receiving chronic opioid therapy

Pain Practice

Volumn 5, Issue 1, 2005, Pages 18-32

  Rozen, Dima ^a   Grass, Gerald W ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Chronic pain; Intraoperative management; Opioid tolerant

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; BACLOFEN; CODEINE; DOXAPRAM; FENTANYL; FENTANYL CITRATE; GABAPENTIN; HALOTHANE; HYDROCODONE; HYDROMORPHONE; ISOFLURANE; LEVORPHANOL; METHADONE; MORPHINE; MORPHINE SULFATE; NALOXONE; NELFINAVIR; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAMORPH SR; OXYCODONE; OXYFAST; OXYLR; PARACETAMOL; PROPOFOL; ROXINOL; SERTRALINE;

ANALGESIA; ANESTHESIST; CANCER PAIN; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG TOLERANCE; DYSPHORIA; EUPHORIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOMAGNESEMIA; INCIDENCE; LIGATION; MIOSIS; NAUSEA AND VOMITING; NONHUMAN; PATIENT CARE; QT PROLONGATION; RESPIRATION DEPRESSION; RESPIRATORY FAILURE; REVIEW; SEDATION; SIDE EFFECT; STOMACH SUCTION; SURGICAL TECHNIQUE; THERMOREGULATION; TORSADE DES POINTES;

EID: 27944476921     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2005.05104.x     Document Type: Review

References (79)

1. Mitra S, Sinatra RS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology. 2004;101:212-227.
2. Elliott AM, Smith BH, Penny KI, et al. The epidemiology of chronic pain in the community. Lancet. 1999;354: 1248-1252.
3. Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage. 2002;23:131-137.
4. Cohen SP, Mullings R, Abdi S. The pharmacologic treatment of muscle pain. Anesthesiology. 2004;101:495-526.
5. International Association for the Study of Pain, S.o.T. Description of chronic pain syndromes and definitions of pain terms. Pain. 1986;Suppl 3:S1-S225.
6. Warfield CA. Principles, Practice of Pain Medicine. 2nd ed. Warfield CA, Bajwa ZH, eds. New York: McGraw-Hill; 2004.
7. Frymoyer JW, Cats-Baril WL. An overview of the incidences and costs of low back pain. Orthop Clin North Am. 1991;22:263-271.
8. Gerdle B, Bjork J, Henriksson C, Bengtsson A. Prevalence of current and chronic pain and their influences upon work and healthcare-seeking: a population study. J Rheumatol. 2004;31:1399-1406.
9. Von Korff M, Dworkin SF, Le Resche L. Graded chronic pain status: an epidemiologic evaluation. Pain. 1990; 40:279-291.
10. Bonica J. Pain research and therapy: past and current status and future needs. In: Ng L, Bonica J, eds. Pain, Discomfort and Humanitarian Care. New York: Elsevier; 1980:1-46.
11. Von Korff M, Wagner EH, Dworkin SF, Saunders KW. Chronic pain and use of ambulatory health care. Psychosom Med. 1991;53:61-79.
12. Kehlet H. Acute pain control and accelerated postoperative surgical recovery. Surg Clin North Am. 1999;79: 431-443.
13. Barratt SM, Smith RC, Kee AJ, et al. Multimodal analgesia and intravenous nutrition preserves total body protein following major upper gastrointestinal surgery. Reg Anesth Pain Med. 2002;27:15-22.
14. Stjernsward J. WHO cancer pain relief programme. Cancer Surv. 1988;7:195-208.
15. Zech DF, Ground R, Lynch J, et al. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63:65-76.
16. Schug SA, Zech D, Dorr U. Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage. 1990;5:27-32.
17. Grond S, Zech D, Lynch J, et al. Validation of World Health Organization guidelines for pain relief in head and neck cancer. A prospective study. Ann Otol Rhinol Laryngol. 1993;102:342-348.
18. Grond S, Zech D, Schug SA, et al. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage. 1991;6:411-422.
19. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943-1953.
20. Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage. 1990;5(1 suppl):S46-S62.
21. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:203-217.
22. Haddox JD, Joranson DE, Angarola RT, et al. Consensus Statement from the American Academy of Pain Medicine and American Pain Society: the use of opioids for the treatment of chronic pain. Clin J Pain. 1997;13:6-11.
23. Collett BJ. Chronic opioid therapy for noncancer pain. Br J Anaesth. 2001;87:133-143.
24. O'Brien CP. Drug addiction and drug abuse. In: Hardman JG, Limbird LE, eds. Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 2001:621-642.
25. Wikler A. Recent progress in research on the neurophysiologic basis of morphine addiction. Am J Psychiatry. 1948;105:329-338.
26. Taub A. Opioid analgesics in the treatment of chronic intractable pain of nonneo-plastic origin. In: Kitahata LM, Collins JG, eds. Narcotic Analgesics in Anaesthesiology. London: Williams & Wilkins; 1982:199-208.
27. Kreek MJ. Medical safety and side effects of methadone in tolerant individuals. JAMA. 1973;223:665-668.
28. Savage SR. Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage. 1996;11: 274-286.
29. Sandgren JE, McPhee M, Greenberger NJ. Narcotic bowel syndrome treated with clonidine. Ann Intern Med. 1984;101:331-334.
30. Gomar C, Carrero EJ. Delayed arousal after general anesthesia associated with baclofen. Anesthesiology. 1994; 81:1306-1307.
31. Wallden J, Thorn SE, Wattwil M. The delay of gastric emptying induced by remifentanil is not influenced by posture. Anesth Analg. 2004;99:429-434, table of contents.
32. Thorn SE, Wattwil M, Lindberg G, Sawe J. Systemic and central effects of morphine on gastroduodenal motility. Acta Anaesthesiol Scand. 1996;40:177-186.
33. Murphy DB, Sutton JA, Prescott LF, Murphy MB. A comparison of the effects of tramadol and morphine on gastric emptying in man. Anaesthesia. 1997;52:1224-1229.
34. Murphy DB, Sutton JA, Prescott LF, Murphy MB. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology. 1997;87:765-770.
35. Roizen MF, Foss JF, Fischer SP. Preoperative evaluation. In: Miller RD, ed. Anesthesia. Philadelphia: Churchill Livingstone; 2000:824-883.
36. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270:2590-2597.
37. Kay GN, Plumb VJ, Arciniegas JG, et al. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol. 1983;2:806-817.
38. Rebeiz AG, Al-Khatib SM. A case of severe ischemia-induced QT prolongation. Clin Cardiol. 2001;24:750.
39. Reardon M, Malik M. QT interval change with age in an overtly healthy older population. Clin Cardiol. 1996; 19:949-952.
40. Ahnve S, Vallin H. Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation. 1982;65:435-439.
41. Ahnve S. QT interval prolongation in acute myocardial infarction. Eur Heart J. 1985;6(suppl D):85-95.
42. Walker PW, Klein D, Kasza L. High dose methadone and ventricular arrhythmias: a report of three cases. Pain. 2002;103:321-324.
43. Gil M, Sala M, Anguera I, et al. QT prolongation and torsades de pointes in patients infected with human immunodeficiency virus and treated with methadone. Am J Cardiol. 2003;92:995-997.
44. Krantz MJ, Lewkowiez L, Hays H, et al. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med. 2002;137:501-504.
45. Rendig SV, Amsterdam EA, Henderson GL, Mason DT. Comparative cardiac contractile actions of six narcotic analgesics: morphine, meperidine, pentazocine, fentanyl, methadone and 1-alpha-acetylmethadol (LAAM). J Pharmacol Exp Ther. 1980;215:259-265.
46. Al-Khatib SM, LaPointe NM, Kramer JM, et al. What clinicians should know about the QT interval. JAMA. 2003;289:2120-2127.
47. Fleisher LA. Risk of anesthesia. In: Miller RD, ed. Anesthesia. Philadelphia: Churchill Livingstone; 2000:795-823.
48. Cohen MM, Duncan PG, Tate RB. Does anesthesia contribute to operative mortality? JAMA. 1988;260:2859-2864.
49. Hynson J, Sessler DI. Intraoperative warming therapies: a comparison of three devices. J Clin Anesth. 1992;4: 194-198.
50. Gourlay GK, Kowalski SR, Plummer JL, et al. The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects. Pain. 1989;37:193-202.
51. Duthie DR, Rowbotham DJ, Wyld R, et al. Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients. Br J Anaesth. 1988;60:614-618.
52. Frolich MA, Giannotti A, Modell JH, Frolich M. Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg. 2001;93:647-648.
53. Pettifer GR, Hosgood G. The effect of rectal temperature on perianesthetic serum concentrations of transdermally administered fentanyl in cats anesthetized with isoflurane. Am J Vet Res. 2003;64:1557-1561.
54. Pettifer GR, Hosgood G. The effect of inhalant anesthetic and body temperature on peri-anesthetic serum concentrations of transdermally administered fentanyl in dogs. Vet Anaesth Analg. 2004;31:109-120.
55. Rose PG, Macfee MS, Boswell MV. Fentanyl transdermal system overdose secondary to cutaneous hyperthermia. Anesth Analg. 1993;77:390-391.
56. Shomaker TS, Zhang J, Ashburn MA. Assessing the impact of heat on the systemic delivery of fentanyl through the transdermal fentanyl delivery system. Pain Med. 2000; 1:225-230.
57. Newshan G. Heat-related toxicity with the fentanyl transdermal patch. J Pain Symptom Manage. 1998;16:277-278.
58. Thompson JP, Bower S, Liddle AM, Rowbotham DJ. Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients. Br J Anaesth. 1998;81:152-154.
59. Murray JM, Rowlands BJ, Trinick TR. Indocyanine green clearance and hepatic function during and after prolonged anaesthesia: comparison of halothane with isoflurane. Br J Anaesth. 1992;68:168-171.
60. Gelman S, Fowler KC, Smith LR. Liver circulation and function during isoflurane and halothane anesthesia. Anesthesiology. 1984;61:726-730.
61. Grundmann U, Zissis A, Bauer C, Bauer M. In vivo effects of halothane, enflurane, and isoflurane on hepatic sinusoidal microcirculation. Acta Anaesthesiol Scand. 1997;41:760-765.
62. Greenblatt EP, Loeb AL, Longnecker DE. Endothelium-dependent circulatory control-a mechanism for the differing peripheral vascular effects of isoflurane versus halothane. Anesthesiology. 1992;77:1178-1185.
63. Landau R, Cahana A, Smiley RM, et al. Genetic variability of mu-opioid receptor in an obstetric population. Anesthesiology. 2004;100:1030-1033.
64. Kim H, Neubert JK, San Miguel A, et al. Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain. 2004;109:488-496.
65. Lipkowski AW, Carr DB, Silbert BS, et al. Non-deterministic individual responses to receptor-selective opioid agonists. Pol J Pharmacol. 1994;46:29-35.
66. Weinrieb RM, Barnett R, Lynch KG, et al. A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients. Liver Transpl. 2004;10:97-106.
67. Peng PW, Sandler AN. A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology. 1999;90:576-599.
68. Gourlay GK, Kowlalski SR, Plummer JL, et al. Fentanyl blood concentrations-analgesic response relationship in the treatment of postoperative pain. Anesth Analg. 1988; 67:329-337.
69. Davis JJ, Johnson KB, Egan TD, et al. Preoperative fentanyl infusion with pharmacokinetic simulation for anesthetic and perioperative management of an opioid-tolerant patient. Anesth Analg. 2003;97:1661-1662.
70. Shafer SL, Varvel JR, Aziz N, et al. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology. 1990;73:1091-1102.
71. Rapp SE, Ready LB, Nessly ML. Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review. Pain. 1995;61:195-201.
72. Jage J, Bey T. Postoperative analgesia in patients with substance use disorders. Acute Pain. 2000;92:140-155.
73. Hord AH. Postoperative analgesia in the opioid-dependent patient. In: Sinatra RS, Hord AH, Ginsberg B, Preble LM, eds. Acute Pain: Mechanisms and Management. St. Louis: Mosby Yearbook; 1992:390-398.
74. Hanks GW, Twycross RG, Lloyd JW. Unexpected complication of successful nerve block. Anaesthesia. 1981; 36:37-39.
75. Hanks GW, Twycross RG, Lloyd JW. Unexpected complication of successful nerve block. Morphine induced respiratory depression precipitated by removal of severe pain. Anaesthesia. 1981;36:37-39.
76. Alsahaf MH, Stockwell M. Respiratory failure due to the combined effects of transdermal fentanyl and epidural bupivacaine/diamorphine following radical nephrectomy. J Pain Symptom Manage. 2000;20:210-213.
77. Saberski L. Postoperative pain management for the patient with chronic pain. In: Sinatra RS, Hord AH, Ginsberg B, Preble LM, eds. Acute Pain: Mechanisms and Management. St. Louis: Mosby Yearbook; 1992:422-431.
78. May JA, White HC, Lenard-White A, et al. The patient recovering from alcohol or drug addiction: special issues for the anesthesiologist. Anesth Analg. 2001;92:160-161.
79. Higa KD, Ho T, Boone KB, Roubicek MC. Narcotic withdrawal syndrome following gastric bypass - a difficult diagnosis. Obes Surg. 2001;11(5):631-4.